US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Sep 2, 2021 (5 years ago)

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Incorrect Instructions

What was recalled

Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01

Recalling firm
Rising Pharmaceuticals
NDC code
16571-752-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0005-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all